SCHEMBL16331528

SCHEMBL16331528

COc1ccc(Nc2nccc3c2cc(-c2ccsc2)n3C)cn1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CYP2A6 P11509 1/20 0.44
▸ FYN P06241 1/20 0.44
▸ PIK3CG P48736 7/20 0.40
▸ PIP4K2A P48426 2/20 0.40
▸ PIK3CA P42336 9/20 0.38
▸ PIK3CD O00329 6/20 0.38
▸ PIK3CB P42338 5/20 0.38
▸ MEN1 O00255 1/20 0.37
▸ USP2 O75604 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ NPC1 O15118 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ TP53 P04637 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ MTOR P42345 3/20 0.36
▸ BACE2 Q9Y5Z0 1/20 0.34
▸ RIPK2 O43353 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16331804 0.87 NPC1 (0.50) FYNMEN1KMT2ANPC1LMNA
SCHEMBL16332015 0.85 FYN (0.48) FYNMEN1KMT2ALMNATP53
SCHEMBL16332162 0.83 FYN (0.42) CYP2A6FYNLMNA
SCHEMBL16331822 0.82 FYN (0.47) FYNMEN1KMT2ANPC1LMNA
SCHEMBL16332052 0.82 FYN (0.39) FYNMEN1KMT2ANPC1LMNA
SCHEMBL16332075 0.82 FYN (0.40) FYNPIP4K2ANPC1LMNATP53
SCHEMBL16331293 0.80 ABCG2 (0.37) FYNPIK3CA
SCHEMBL16331728 0.79 TGFBR1 (0.45) PIP4K2A
SCHEMBL16331999 0.79 CTSC (0.44) FYNPIK3CGPIP4K2AMEN1KMT2A
SCHEMBL16373693 0.78 FYN (0.46) FYNPIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9458463-B2 Method for treatment of diabetes by a small molecule inhibitor for GRK5 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2016-10-04 — — US claimed
EP-2818472-A1 Imidazo[4,5-c]pyridine and pyrrolo[3,2-c]pyridine compounds as G-protein-coupled receptor kinase 5 (GRK5) modulators Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2014-12-31 — — EP claimed
EP-2818472-A1 Imidazo[4,5-c]pyridine and pyrrolo[3,2-c]pyridine compounds as G-protein-coupled receptor kinase 5 (GRK5) modulators Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2014-12-31 — — EP disclosed
Send feedback